Rekvina Labs Ltd
₹0.00▲ +0.00 (+0.00%)
526075·NSE·Healthcare
Market Cap
16.00 Cr
PE Ratio
—
Volume
—
Day High - Low
—
52W High-Low
46.65 - 6.75
₹0.00▲ +0.00 (+0.00%)
Market Cap16.00 Cr
PE Ratio—
Volume—
Day High - Low—
52W High-Low46.65 - 6.75
Rekvina Labs Ltd (526075): company summary
Rekvina Labs Ltd (526075) is a micro-cap Healthcare company valued at ₹16 crore operating in Pharmaceuticals on the NSE and BSE.
Rekvina Labs Ltd (526075) is a micro-cap Healthcare company valued at ₹16 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Return on equity stands at 41.3%, a strong return on shareholder capital.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -13.08 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
41.27%
Strong
P/E
—
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Weak
Price performance
52W₹6.75
₹46.65
DocStoX take
Supported by growth (7.5), but weakest on risk (4.2). Scored on 3 of 5 measures.
DocStoX score
Low confidence5.3
/10
Weak
Quality
Modest
ROE 41.3%
Valuation
No data
No valuation multiples
Growth
Strong
Revenue +45.4% 10Y CAGR
Risk
Elevated
D/E 0.00
Momentum
No data
No technical indicators
Scored on 3 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹16 Cr
52W High / Low
₹47 / ₹7
Dividend Yield
0.00%
Promoter Holding
41.30%
EPS (TTM)
₹-0.12
Book Value
—
Key highlights
- Revenue compounding 45% a year
- Capital works hard — ROCE 41%
- Strong returns on equity (41%)
- Loss-making in some of the last 5 years
- Small ₹16 cr company — thinner liquidity
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Rekvina Labs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Rekvina Labs Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Rekvina Labs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing